Abu El-Asrar AM - Search Results

1

Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt-Koyanagi-Harada disease.

Abu El-Asrar AM, AlBloushi AF, Alzubaidi A, Gikandi PW, Stefánsson E. Abu El-Asrar AM, et al. Acta Ophthalmol. 2024 Mar 12. doi: 10.1111/aos.16669. Online ahead of print. Acta Ophthalmol. 2024. PMID: 38470990

2

Prognostic factors in Vogt-Koyanagi-Harada disease.

Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D, Abu El-Asrar AM. Al-Kharashi AS, et al. Int Ophthalmol. 2007 Apr-Jun;27(2-3):201-10. doi: 10.1007/s10792-007-9062-9. Epub 2007 Apr 14. Int Ophthalmol. 2007. PMID: 17435968

3

Vogt-Koyanagi-Harada disease in children.

Abu El-Asrar AM, Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D. Abu El-Asrar AM, et al. Eye (Lond). 2008 Sep;22(9):1124-31. doi: 10.1038/sj.eye.6702859. Epub 2007 May 4. Eye (Lond). 2008. PMID: 17479116

4

The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.

Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM. Abu El-Asrar AM, et al. Acta Ophthalmol. 2012 Dec;90(8):e603-8. doi: 10.1111/j.1755-3768.2012.02498.x. Epub 2012 Sep 12. Acta Ophthalmol. 2012. PMID: 22971163 Free article.

5

Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.

Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D. Abu El-Asrar AM, et al. Acta Ophthalmol. 2013 Sep;91(6):e486-93. doi: 10.1111/aos.12127. Epub 2013 Apr 10. Acta Ophthalmol. 2013. PMID: 23575246 Free article.

6

Patterns of Uveitis in a University-based Tertiary Referral Center in Riyadh, Saudi Arabia.

Al Dhahri H, Al Rubaie K, Hemachandran S, Mousa A, Gikandi PW, Al-Mezaine HS, Abu El-Asrar AM. Al Dhahri H, et al. Ocul Immunol Inflamm. 2015 Aug;23(4):311-319. doi: 10.3109/09273948.2014.939197. Epub 2014 Jul 24. Ocul Immunol Inflamm. 2015. PMID: 25058456

7

Vitreous hemorrhage in pediatric age group.

AlHarkan DH, Kahtani ES, Gikandi PW, Abu El-Asrar AM. AlHarkan DH, et al. J Ophthalmol. 2014;2014:497083. doi: 10.1155/2014/497083. Epub 2014 Nov 19. J Ophthalmol. 2014. PMID: 25505975 Free PMC article.

8

Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.

Abouammoh MA, Gupta V, Hemachandran S, Herbort CP, Abu El-Asrar AM. Abouammoh MA, et al. Acta Ophthalmol. 2016 Sep;94(6):573-8. doi: 10.1111/aos.12974. Epub 2016 Jan 29. Acta Ophthalmol. 2016. PMID: 26823203 Free article.

9

Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.

Abu El-Asrar AM, Al Mudhaiyan T, Al Najashi AA, Hemachandran S, Hariz R, Mousa A, Al-Muammar A. Abu El-Asrar AM, et al. Ocul Immunol Inflamm. 2017 Aug;25(4):475-485. doi: 10.3109/09273948.2016.1139730. Epub 2016 Mar 22. Ocul Immunol Inflamm. 2017. PMID: 27003480

10

Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.

Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A. Abu El-Asrar AM, et al. Acta Ophthalmol. 2017 Feb;95(1):85-90. doi: 10.1111/aos.13189. Epub 2016 Aug 18. Acta Ophthalmol. 2017. PMID: 27535102 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

225 results

Search Page